Precision BioSciences Inc (DTIL)
9.85
+0.03
(+0.31%)
USD |
NASDAQ |
Apr 25, 16:00
9.85
0.00 (0.00%)
After-Hours: 17:00
Precision BioSciences Cash and Short Term Investments (Quarterly): 116.68M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 116.68M |
September 30, 2023 | 122.23M |
June 30, 2023 | 137.79M |
March 31, 2023 | 158.13M |
December 31, 2022 | 189.58M |
September 30, 2022 | 212.05M |
June 30, 2022 | 184.14M |
March 31, 2022 | 116.22M |
December 31, 2021 | 143.66M |
September 30, 2021 | 160.47M |
June 30, 2021 | 173.94M |
Date | Value |
---|---|
March 31, 2021 | 193.46M |
December 31, 2020 | 89.80M |
September 30, 2020 | 104.15M |
June 30, 2020 | 126.89M |
March 31, 2020 | 154.19M |
December 31, 2019 | 180.89M |
September 30, 2019 | 206.26M |
June 30, 2019 | 226.10M |
March 31, 2019 | 116.50M |
December 31, 2018 | 103.19M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
89.80M
Minimum
Dec 2020
226.10M
Maximum
Jun 2019
157.72M
Average
158.13M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Altimmune Inc | 197.82M |
BioVie Inc | 20.23M |
Adial Pharmaceuticals Inc | 2.827M |
Gritstone Bio Inc | 79.27M |
Humacyte Inc | 80.45M |